|
시장보고서
상품코드
1935154
바이오엔지니어링 스텐트 시장 : 용도별, 제품 유형별, 투여 방법별, 재질별, 최종사용자별, 지역별Bio-engineered Stent Market, By Application Type, By Product Type, By Mode of Delivery, By Material Type, By End User, By Geography |
||||||
바이오엔지니어링 스텐트 시장은 2026년에 57억 4,760만 달러로 추정되며, 2033년까지 99억 6,030만 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 8.7%를 나타낼 전망입니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 57억 4,760만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.70% | 2033년 예측 : | 99억 6,030만 달러 |
바이오 엔지니어링 스텐트는 막힌 동맥을 치료하는 데 사용되는 짧고 얇은 금속 또는 플라스틱 튜브로 구성되어 있습니다. 관상동맥성 심질환, 허혈성 심질환 등 다양한 심혈관 질환을 앓고 있는 환자들이 이용하고 있습니다. 시장에서는 관상동맥질환, 말초동맥질환, 경동맥질환, 경동맥질환, 신장동맥협착증, 복부대동맥류, 흉부대동맥류 등 다양한 질환에 대응하는 다양한 바이오엔지니어링 스텐트가 제공되고 있습니다.
시장 역학
신장 질환의 유병률 증가는 바이오 엔지니어링 스텐트 시장의 성장을 이끄는 주요 요인입니다. 미국심장협회위원회에 따르면, 2015년 심혈관 질환은 전 세계 사망원인 1위로 연간 1,790만 명 이상이 사망하는 것으로 보고되었으며, 2030년까지 2,360만 명 이상으로 증가할 것으로 예측됩니다. 이 소식통에 따르면, 2015년 미국에서 심혈관 질환으로 사망한 사람은 약 83만 6,546명으로 전체 사망자 중 약 3명 중 1명이 심혈관 질환으로 사망한 것으로 나타났습니다.
또한, 시장의 주요 기업들은 시장에서의 입지를 강화하기 위해 신제품 출시 및 승인, 제휴 및 협력 등 다양한 전략을 채택하는 데 주력하고 있습니다. 예를 들어, 2017년 5월, 메드트로닉은 미국 식품의약국(FDA)의 승인을 받아 Resolute Onyx 4.5mm 및 5mm 크기의 약물 용출 스텐트를 출시하였습니다. 이 장치는 Resolute Integrity의 임상적 성능과 우수한 전달성을 입증했습니다. 본 제품은 미국 내 관상동맥질환 환자 치료를 목적으로 합니다.
그러나 심장 질환 치료에서 대체품의 가용성, 제품 유형의 리콜 및 고장, 제품 유형 승인에 대한 엄격한 규제는 시장 성장을 저해하는 요인으로 작용할 것으로 예측됩니다. 예를 들어, 2017년 11월, Abbott는 Xience 금속 약물용출 스텐트로 치료받은 환자에 비해 심근경색, 스텐트 혈전증과 같은 심각한 부작용 발생률이 높다는 이유로 흡수성 관상동맥 약물용출 스텐트인 흡수성 혈관스캐폴드(BVS) 시스템을 Class 1의 장치 리콜로 회수하였습니다.
본 조사의 주요 특징
- 이 보고서는 2017년을 기준 연도로 하여 바이오엔지니어링 스텐트 시장의 상세한 분석과 예측 기간(2018년-2026년) 시장 규모 및 CAGR%에 대해 조사 분석하였습니다.
- 각 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 기업 개요, 재무 성과, 제품 유형 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략 및 향후 계획과 같은 매개 변수를 기반으로 세계 바이오 엔지니어링 스텐트 시장의 주요 업체를 프로파일링합니다.
- 이 보고서는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 바이오엔지니어링 스텐트 시장 보고서는 투자자, 공급업체, 제품 유형 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 바이오엔지니어링 스텐트 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 바이오엔지니어링 스텐트 시장 : 용도별, 2026년-2033년
제5장 세계의 바이오엔지니어링 스텐트 시장 : 제품 유형별, 2026년-2033년
제6장 세계의 바이오엔지니어링 스텐트 시장 : 투여 방법별, 2026년-2033년
제7장 세계의 바이오엔지니어링 스텐트 시장 : 재료 유형별, 2026년-2033년
제8장 세계의 바이오엔지니어링 스텐트 시장 : 최종사용자별, 2026년-2033년
제9장 세계의 바이오엔지니어링 스텐트 시장 : 지역별, 2026년-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.03.09Bio-engineered Stent Market is estimated to be valued at USD 5,747.60 Mn in 2026 and is expected to reach USD 9,960.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5,747.60 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.70% | 2033 Value Projection: | USD 9,960.3 Mn |
Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.
Market Dynamics
Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths.
Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S.
However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.
Key features of the study
- This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global bio-engineered stents market based on the following parameters - company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market
Market Segmentation
- By Application Type
- Coronary artery disease
- Peripheral arterial disease
- Carotid Artery Disease
- Renal Artery Stenosis
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm
- Others
- By Product Type
- Drug-eluting Stents
- Bioabsorbable Stents
- Drug-eluting balloons
- By Mode of Delivery
- Balloon-expandable Stents
- Self-expanding Stents
- By Material Type
- Metal-based
- Polymer-based
- By End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Medtronic, plc.
- Boston Scientific Corporation
- Abbott Laboratories
- Biotronik SE & Co. KG
- Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- Stentys Sao
- Meril Life Sciences Pvt. Ltd
- Vascular Concepts
- L. Gore and Associates
- R. Bard
- Endologix, Inc.
- Lombard Medical Technologies
- Translumina GmbH
- JOTEC GmbH
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application Type
- Market Snippet, By Product Type
- Market Snippet, By Material Type
- Market Snippet, By Mode of Delivery
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- PORTER's Analysis
- Mergers and Acquisitions
- Epidemiology
4. Global Bio-engineered Stent Market, By Application Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Coronary artery disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Peripheral arterial disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Carotid Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Renal Artery Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Abdominal Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Thoracic Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Bio-engineered Stent Market, By Product Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Drug-eluting Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Bioabsorbable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Drug-eluting balloons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Bio-engineered Stent Market, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Balloon-expandable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Self-expanding Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Bio-engineered Stent Market, By Material Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Metal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Polymer-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
8. Global Bio-engineered Stent Market, By End User, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Hospitals & Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
9. Global Bio-engineered Stent Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2033
- North America
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Medtronic, plc.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boston Scientific Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott Laboratories
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BIOTRONIK SE & Co. KG
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Terumo Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- MicroPort Scientific Corporation
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- STENTYS SA
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Meril Life Sciences Pvt. Ltd.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vascular Concepts
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- W. L. Gore and Associates
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- C. R. Bard
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Endologix, Inc.
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lombard Medical Technologies
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Translumina GmbH
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- JOTEC GmbH
- Company Overview
- Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Medtronic, plc.
11. Section
- References
- Research Methodology
- About Us and Sales Contact
